Bank of America
ONCO icon

Bank of America’s Onconetix ONCO Stock Holding History

Bank of America’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Hold
0
– -$17 – 6540
2025
Q4 		– Hold
0
– – – 7152
2025
Q3 		– Hold
0
– – – 8091
2025
Q2 		– Hold
0
– – – 8323
2025
Q1 		– Hold
0
– – – 8233
2024
Q4 		– Sell
-1
Closed -$10.1K – 7891
2024
Q3 		$28.4K Hold
1
– – ﹤0.01% 6679
2024
Q2 		$20.9K Hold
1
– – ﹤0.01% 6733
2024
Q1 		$19.3K Hold
1
– – ﹤0.01% 6756
2023
Q4 		$24.8K Hold
1
– – ﹤0.01% 6747
2023
Q3 		$63.9K Hold
1
– – ﹤0.01% 6423
2023
Q2 		$141K Buy
+1
New +$174K ﹤0.01% 6048
2023
Q1 		– Hold
0
– -$11 – 8143
2022
Q4 		– Hold
0
– – – 8069
2022
Q2 		– Hold
0
– -$40K – 8272
2022
Q1 		– Hold
0
– – – 7266

Other funds holding ONCO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Bank of America's ONCO Position: Q1 2026 in Review

Bank of America held its Onconetix (ONCO) position steady in Q1 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6540.

Bank of America first reported a position in ONCO in Q2 2023 and has held it in 6 quarters since. The position peaked at $141K in Q2 2023. 5 funds tracked by Wall St. Rank hold ONCO as of Q1 2026.

  • Bank of America held 0 shares of Onconetix worth $0 as of Q1 2026.
  • Bank of America left its Onconetix share count unchanged in Q1 2026.
  • Onconetix made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #6540 holding.
  • Bank of America first reported a position in Onconetix in Q2 2023 and has held it in 6 quarters since.
  • Bank of America's Onconetix position peaked at $141K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Onconetix as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.